MINI FUTURE SHORT - DIASORIN Stock

DE000PN4VNQ2

Market Closed - Deutsche Boerse AG 03:20:43 2024-05-17 pm EDT
3.82 ^EUR	-0.78%

Current month	-15.30%
1 month	-22.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Latest news about DIASORIN S.P.A.

DiaSorin receives clearance from US FDA for NxTAG panel	May. 17	AN
DiaSorin S p A : receives FDA 510(k) clearance for the updated syndromic panel NxTAG® Respiratory Pathogen Panel v2	May. 16	PU
Funds move on DiaSorin and Leonardo on the Mib.	May. 16	AN
Futures bullish; traders believe in Fed cut	May. 16	AN

More news

Quotes 5-day view

Date	Price	Change
24-05-17	3.82	-0.78%
24-05-16	3.85	-0.52%
24-05-15	3.87	+6.32%
24-05-14	3.64	-5.45%
24-05-13	3.85	-6.78%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 03:20 pm EDT

More quotes

Static data

Product type	Knock-Out mit Stop Loss
Buy / Sell	PUT
Underlying	DIASORIN S.P.A.
Issuer	BNP Paribas
WKN	PN4VNQ
ISIN	DE000PN4VNQ2
Date issued	2023-06-16
Strike	139.7 €
Maturity	Unlimited
Parity	10 : 1
Emission price	4.19 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	5.87 €
Lowest since issue	3.64 €

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company

Ratings for DiaSorin S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: DiaSorin S.p.A.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

102 EUR

Average target price

99.87 EUR

Spread / Average Target

-2.14%

Consensus